Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of anakinra in Still's disease (adult-onset and juvenile-onset) has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Still Disease

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Still's Disease, Adult-Onset, Still's Disease, Juvenile-Onset | Phase 3 | Status: TERMINATED | Results posted: 2020-04-28